
Co-Diagnostics CODX
$ 4.4
101.83%
Quarterly report 2025-Q3
added 11-13-2025
Co-Diagnostics Operating Cycle 2011-2026 | CODX
Annual Operating Cycle Co-Diagnostics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 405 | 373 | 219 | 235 | 863 | 828 | 11 K | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 11 K | 219 | 1.98 K |
Quarterly Operating Cycle Co-Diagnostics
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3.86 K | 3.18 K | 4.8 K | - | 471 | - | - | - | 1.68 K | 1.87 K | 1.43 K | - | 784 | 787 | 181 | - | 144 | 229 | 253 | - | 176 | 168 | 1.14 K | - | 1.17 K | 658 | 23.7 K | - | 126 | 126 | 63.1 | - | 2.74 K | 2.74 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 23.7 K | 63.1 | 2.19 K |
Operating Cycle of other stocks in the Diagnostics research industry
| Issuer | Operating Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Agilent Technologies
A
|
161 | $ 110.3 | -2.8 % | $ 33.5 B | ||
|
Centogene N.V.
CNTG
|
170 | - | -6.23 % | $ 30.6 M | ||
|
Soleno Therapeutics
SLNO
|
1.04 K | $ 30.28 | -4.87 % | $ 1.54 B | ||
|
Enzo Biochem
ENZ
|
206 | - | -8.98 % | $ 14.8 K | ||
|
Exact Sciences Corporation
EXAS
|
91.7 | - | - | $ 19.8 B | ||
|
Neuronetics
STIM
|
69.1 | $ 1.4 | 4.89 % | $ 92.3 M | ||
|
Akumin
AKU
|
57.4 | - | -17.87 % | $ 25.9 M | ||
|
Sotera Health Company
SHC
|
80.3 | $ 13.25 | -2.18 % | $ 3.76 B | ||
|
Heska Corporation
HSKA
|
177 | - | - | $ 1.31 B | ||
|
Trinity Biotech plc
TRIB
|
299 | $ 0.61 | -0.7 % | $ 61.9 M | ||
|
BioNano Genomics
BNGO
|
315 | $ 1.15 | - | $ 6.26 M | ||
|
Twist Bioscience Corporation
TWST
|
96.1 | $ 44.54 | -4.74 % | $ 2.66 B | ||
|
DermTech
DMTK
|
114 | - | -11.32 % | $ 2.94 M | ||
|
Aspira Women's Health
AWH
|
73.8 | - | -6.19 % | $ 10.5 M | ||
|
Accelerate Diagnostics
AXDX
|
489 | - | -61.36 % | $ 2.46 M | ||
|
Global Cord Blood Corporation
CO
|
202 | - | - | $ 399 M | ||
|
Genetic Technologies Limited
GENE
|
11.8 K | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
185 | - | 0.12 % | $ 80.1 M | ||
|
HTG Molecular Diagnostics
HTGM
|
216 | - | -20.0 % | $ 1.06 M | ||
|
Castle Biosciences
CSTL
|
97.9 | $ 23.99 | -2.87 % | $ 666 M | ||
|
PRA Health Sciences, Inc.
PRAH
|
1.22 K | - | - | $ 10.7 B | ||
|
Charles River Laboratories International
CRL
|
65 | $ 159.38 | -3.48 % | $ 7.9 B | ||
|
Quest Diagnostics Incorporated
DGX
|
54.2 | $ 196.09 | -1.04 % | $ 21.8 B | ||
|
Organovo Holdings
ONVO
|
79.8 | - | -2.3 % | $ 19.4 M | ||
|
OpGen
OPGN
|
4.66 | - | -16.95 % | $ 1.54 M | ||
|
DarioHealth Corp.
DRIO
|
227 | $ 8.45 | - | $ 33.7 M | ||
|
Waters Corporation
WAT
|
834 | $ 289.91 | -3.54 % | $ 17.3 B | ||
|
Biocept
BIOC
|
134 | - | -13.05 % | $ 7.29 M | ||
|
Illumina
ILMN
|
198 | $ 117.59 | -5.48 % | $ 18.7 B | ||
|
PerkinElmer
PKI
|
92.2 | - | -0.91 % | $ 14.7 B | ||
|
Invitae Corporation
NVTA
|
368 | - | - | $ 21.2 M | ||
|
Interpace Biosciences
IDXG
|
79.2 | $ 1.68 | -2.89 % | $ 7.37 M | ||
|
Motus GI Holdings
MOTS
|
3.45 K | - | -34.28 % | $ 263 K | ||
|
QIAGEN N.V.
QGEN
|
172 | - | - | $ 10.6 B | ||
|
Neogen Corporation
NEOG
|
213 | $ 8.85 | -3.33 % | $ 1.92 B | ||
|
Chembio Diagnostics
CEMI
|
164 | - | 0.22 % | $ 16.8 M | ||
|
Personalis
PSNL
|
55.8 | $ 6.33 | -13.59 % | $ 375 M | ||
|
Laboratory Corporation of America Holdings
LH
|
71.8 | $ 264.96 | -1.27 % | $ 22 B | ||
|
Senseonics Holdings
SENS
|
104 | $ 6.45 | -1.68 % | $ 269 M | ||
|
Psychemedics Corporation
PMD
|
61.3 | - | -1.84 % | $ 15.3 M | ||
|
Precipio
PRPO
|
49.8 | $ 25.68 | -3.24 % | $ 33.3 M | ||
|
CareDx, Inc
CDNA
|
51.5 | $ 16.68 | -4.52 % | $ 889 M | ||
|
Quotient Limited
QTNT
|
432 | - | -11.32 % | $ 1.1 M | ||
|
Syneos Health
SYNH
|
102 | - | - | $ 4.46 B | ||
|
Renalytix AI plc
RNLX
|
15.9 | - | 5.66 % | $ 22.7 M | ||
|
VolitionRx Limited
VNRX
|
52.3 | $ 0.2 | 1.97 % | $ 19.2 M | ||
|
Biodesix
BDSX
|
41.7 | $ 14.27 | -2.26 % | $ 1.85 B |